Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Urapidil market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Urapidilmarket, defines the market attractiveness level of Urapidil market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Urapidil industry, describes the types of Urapidil market, the applications of major players and the market size, and deeply analyzes the current situation of the global Urapidil market and the development prospects and opportunities of Urapidil industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Urapidil market in Chapter 13.
By Player:
Takeda
Sanwa Kagaku Kenkyusho
AbbVie
Kaken Pharm
Abbott
Huayu (Wuxi) Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangzhou Wanzheng Pharmaceutical
Hebei Yipin Pharmaceutical
Xi'an Lijun Pharmaceutical
Tonghua Jinma Pharmaceutical Group
Changchun Tiancheng Pharmaceutical
Heilongjiang Fuhe Pharmaceutical Group
By Type:
Injection
Tablets
By End-User:
Severe Hypertension And Refractory Hypertension
Control Perioperative Hypertension
Essential Hypertension
Renal Hypertension
High Blood Pressure Caused By Pheochromocytoma
Congestive Heart Failure
Dysuria
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Urapidil Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Urapidil Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Urapidil Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Urapidil Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Urapidil Market Analysis and Outlook to 2022
-
7.1 Global Urapidil Consumption (2017-2022)
-
7.2 United States Urapidil Consumption (2017-2022)
-
7.3 Europe Urapidil Consumption (2017-2022)
-
7.4 China Urapidil Consumption (2017-2022)
-
7.5 Japan Urapidil Consumption (2017-2022)
-
7.6 India Urapidil Consumption (2017-2022)
-
7.7 South Korea Urapidil Consumption (2017-2022)
8 Region and Country-wise Urapidil Market Analysis and Outlook to 2028
-
8.1 Global Urapidil Consumption Forecast (2022-2028)
-
8.2 United States Urapidil Consumption Forecast (2022-2028)
-
8.3 Europe Urapidil Consumption Forecast (2022-2028)
-
8.4 China Urapidil Consumption Forecast (2022-2028)
-
8.5 Japan Urapidil Consumption Forecast (2022-2028)
-
8.6 India Urapidil Consumption Forecast (2022-2028)
-
8.7 South Korea Urapidil Consumption Forecast (2022-2028)
9 Global Urapidil Market Outlook by Types and Applications to 2022
-
9.1 Global Urapidil Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Urapidil Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Severe Hypertension And Refractory Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Control Perioperative Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Essential Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Renal Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.5 Global High Blood Pressure Caused By Pheochromocytoma Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Congestive Heart Failure Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Dysuria Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Other Consumption and Growth Rate (2017-2022)
10 Global Urapidil Market Outlook by Types and Applications to 2028
-
10.1 Global Urapidil Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Urapidil Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Severe Hypertension And Refractory Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Control Perioperative Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Essential Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Renal Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global High Blood Pressure Caused By Pheochromocytoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Congestive Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Dysuria Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Urapidil Import and Export Analysis (Top 5 Countries)
-
11.1 Global Urapidil Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Urapidil Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Urapidil Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Urapidil Market Competitive Analysis
-
14.1 Takeda
-
14.1.1 Takeda Company Details
-
14.1.2 Takeda Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Urapidil Product and Service
-
14.2 Sanwa Kagaku Kenkyusho
-
14.2.1 Sanwa Kagaku Kenkyusho Company Details
-
14.2.2 Sanwa Kagaku Kenkyusho Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanwa Kagaku Kenkyusho Urapidil Product and Service
-
14.3 AbbVie
-
14.3.1 AbbVie Company Details
-
14.3.2 AbbVie Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AbbVie Urapidil Product and Service
-
14.4 Kaken Pharm
-
14.4.1 Kaken Pharm Company Details
-
14.4.2 Kaken Pharm Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Kaken Pharm Urapidil Product and Service
-
14.5 Abbott
-
14.5.1 Abbott Company Details
-
14.5.2 Abbott Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Abbott Urapidil Product and Service
-
14.6 Huayu (Wuxi) Pharmaceutical
-
14.6.1 Huayu (Wuxi) Pharmaceutical Company Details
-
14.6.2 Huayu (Wuxi) Pharmaceutical Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Huayu (Wuxi) Pharmaceutical Urapidil Product and Service
-
14.7 Shandong Luoxin Pharmaceutical Group
-
14.7.1 Shandong Luoxin Pharmaceutical Group Company Details
-
14.7.2 Shandong Luoxin Pharmaceutical Group Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Shandong Luoxin Pharmaceutical Group Urapidil Product and Service
-
14.8 Guangzhou Wanzheng Pharmaceutical
-
14.8.1 Guangzhou Wanzheng Pharmaceutical Company Details
-
14.8.2 Guangzhou Wanzheng Pharmaceutical Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Guangzhou Wanzheng Pharmaceutical Urapidil Product and Service
-
14.9 Hebei Yipin Pharmaceutical
-
14.9.1 Hebei Yipin Pharmaceutical Company Details
-
14.9.2 Hebei Yipin Pharmaceutical Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Hebei Yipin Pharmaceutical Urapidil Product and Service
-
14.10 Xi'an Lijun Pharmaceutical
-
14.10.1 Xi'an Lijun Pharmaceutical Company Details
-
14.10.2 Xi'an Lijun Pharmaceutical Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Xi'an Lijun Pharmaceutical Urapidil Product and Service
-
14.11 Tonghua Jinma Pharmaceutical Group
-
14.11.1 Tonghua Jinma Pharmaceutical Group Company Details
-
14.11.2 Tonghua Jinma Pharmaceutical Group Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Tonghua Jinma Pharmaceutical Group Urapidil Product and Service
-
14.12 Changchun Tiancheng Pharmaceutical
-
14.12.1 Changchun Tiancheng Pharmaceutical Company Details
-
14.12.2 Changchun Tiancheng Pharmaceutical Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Changchun Tiancheng Pharmaceutical Urapidil Product and Service
-
14.13 Heilongjiang Fuhe Pharmaceutical Group
-
14.13.1 Heilongjiang Fuhe Pharmaceutical Group Company Details
-
14.13.2 Heilongjiang Fuhe Pharmaceutical Group Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Heilongjiang Fuhe Pharmaceutical Group Urapidil Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Urapidil
-
Figure Urapidil Picture
-
Table Global Urapidil Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Urapidil Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Urapidil Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Urapidil Consumption by Country (2017-2022)
-
Figure United States Urapidil Consumption and Growth Rate (2017-2022)
-
Table Europe Urapidil Consumption and Growth Rate (2017-2022)
-
Figure China Urapidil Consumption and Growth Rate (2017-2022)
-
Figure Japan Urapidil Consumption and Growth Rate (2017-2022)
-
Figure India Urapidil Consumption and Growth Rate (2017-2022)
-
Figure South Korea Urapidil Consumption and Growth Rate (2017-2022)
-
Figure Global Urapidil Consumption Forecast by Country (2022-2028)
-
Figure United States Urapidil Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Urapidil Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Urapidil Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Urapidil Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Urapidil Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Urapidil Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Severe Hypertension And Refractory Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Control Perioperative Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Essential Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Renal Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global High Blood Pressure Caused By Pheochromocytoma Consumption and Growth Rate (2017-2022)
-
Figure Global Congestive Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Dysuria Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Severe Hypertension And Refractory Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Control Perioperative Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Essential Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renal Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global High Blood Pressure Caused By Pheochromocytoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Congestive Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dysuria Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Urapidil Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Urapidil Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Urapidil Product and Service
-
Table Sanwa Kagaku Kenkyusho (Foundation Year, Company Profile and etc.)
-
Table Sanwa Kagaku Kenkyusho Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanwa Kagaku Kenkyusho Urapidil Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Urapidil Product and Service
-
Table Kaken Pharm (Foundation Year, Company Profile and etc.)
-
Table Kaken Pharm Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kaken Pharm Urapidil Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Urapidil Product and Service
-
Table Huayu (Wuxi) Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Huayu (Wuxi) Pharmaceutical Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Huayu (Wuxi) Pharmaceutical Urapidil Product and Service
-
Table Shandong Luoxin Pharmaceutical Group (Foundation Year, Company Profile and etc.)
-
Table Shandong Luoxin Pharmaceutical Group Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shandong Luoxin Pharmaceutical Group Urapidil Product and Service
-
Table Guangzhou Wanzheng Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Guangzhou Wanzheng Pharmaceutical Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guangzhou Wanzheng Pharmaceutical Urapidil Product and Service
-
Table Hebei Yipin Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Hebei Yipin Pharmaceutical Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hebei Yipin Pharmaceutical Urapidil Product and Service
-
Table Xi'an Lijun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Xi'an Lijun Pharmaceutical Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xi'an Lijun Pharmaceutical Urapidil Product and Service
-
Table Tonghua Jinma Pharmaceutical Group (Foundation Year, Company Profile and etc.)
-
Table Tonghua Jinma Pharmaceutical Group Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tonghua Jinma Pharmaceutical Group Urapidil Product and Service
-
Table Changchun Tiancheng Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Changchun Tiancheng Pharmaceutical Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Changchun Tiancheng Pharmaceutical Urapidil Product and Service
-
Table Heilongjiang Fuhe Pharmaceutical Group (Foundation Year, Company Profile and etc.)
-
Table Heilongjiang Fuhe Pharmaceutical Group Urapidil Sales, Price, Value and Gross Profit (2017-2022)
-
Table Heilongjiang Fuhe Pharmaceutical Group Urapidil Product and Service
-
